Brinker Capital Investments’s Accelerate Diagnostics AXDX Stock Holding History

Brinker Capital Investments’s Portfolio AXDX Stock Details AXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-500	Closed	-$85K	–	340
2019 Q4	$85K	Hold	500	–	–	﹤0.01%	379
2019 Q3	$93K	Hold	500	–	–	﹤0.01%	374
2019 Q2	$114K	Hold	500	–	–	﹤0.01%	460
2019 Q1	$105K	Hold	500	–	–	﹤0.01%	385
2018 Q4	$58K	Hold	500	–	–	﹤0.01%	382
2018 Q3	$115K	Hold	500	–	–	﹤0.01%	318
2018 Q2	$112K	Hold	500	–	–	﹤0.01%	327
2018 Q1	$114K	Hold	500	–	–	﹤0.01%	312
2017 Q4	$131K	Hold	500	–	–	﹤0.01%	311
2017 Q3	$112K	Hold	500	–	–	﹤0.01%	301
2017 Q2	$137K	Buy	+500	New	+$136K	0.01%	286

Other funds holding AXDX

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAM

Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Brinker Capital Investments's AXDX Position: Q1 2020 in Review

Brinker Capital Investments sold out of Accelerate Diagnostics (AXDX) in Q1 2020, closing a stake of 500 shares — an estimated $85K sold.

Brinker Capital Investments first reported a position in AXDX in Q2 2017 and held it in 11 quarters. The position peaked at $137K in Q2 2017. 110 funds tracked by Wall St. Rank hold AXDX as of Q1 2020.

Brinker Capital Investments reported no remaining Accelerate Diagnostics position as of Q1 2020 after selling out during the quarter.
Brinker Capital Investments sold 500 Accelerate Diagnostics shares in Q1 2020, an estimated $85K.
Brinker Capital Investments first reported a position in Accelerate Diagnostics in Q2 2017 and held it in 11 quarters.
Brinker Capital Investments's Accelerate Diagnostics position peaked at $137K in Q2 2017.
110 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q1 2020.

Based on Brinker Capital Investments's 13F filing for Q1 2020, filed 13 May 2020.